The Inside Story: The Six-Month Window
Skip to content
Stephen Saad said you have to be within six months of the first launch to be part of market formation. This week Africa’s largest drugmaker won approval to sell a generic Ozempic in Canada — and then discovered it has no ingredient to make it with.
The intelligence satisfies curiosity. The paid briefings satisfy strategy.
Every Monday, Elite subscribers receive an Investor Memo breaking down the deal, the structure and the positioning behind the week’s most consequential African wealth story – the kind of analysis that doesn’t appear anywhere else.
Twice a month, a Wealth Intelligence brief profiles a single billionaire’s holdings, cash flows and expansion pipeline in detail no public source matches.
→ Executive ($25/mo): Daily newsletter + Deep-Dive Reports
→ Elite ($75/mo): Everything above + Investor Memos + Wealth Intelligence + Quarterly Analyst Briefings
Subscribe now
This post is for paying subscribers only
Subscribe
Already have an account? Sign In
Crédito: Link de origem